SwePub - search: L773:1098 3015

Enumeration	Reference	Cover	Find
1.	Nystrand, Camilla, et al. (author) Indicated Parenting Interventions and Long Term Outcomes : A Health Economic Modeling Study 2018 In: Value in Health. - : Elsevier. - 1098-3015 .- 1524-4733. ; 21, s. S76-S76 Conference paper (peer-reviewed)abstract Economic evaluations of early interventions for children are augmenting in numbers and a larger focus is put on the longer-term economic returns. However, little is known about the labour market returns from preventive parenting programs. This study estimates the benefits and costs of five parenting interventions: Comet, Connect, the Incredible Years (IY), Cope and bibliotherapy, compared to a waitlist control, for the prevention of persistent externalizing behavior problems in children.
2.	Bolin, Kristian, et al. (author) Smoking-cessation therapy using varenicline - The cost-utility of an additional 12-week course of varenicline for the maintenance of smoking abstinence 2008 In: Value in Health. - 1098-3015. ; 11:3, s. 275-275 Conference paper (peer-reviewed)
3.	Mörk, Ann-Christin, et al. (author) Cost of Ilness for adults with partial epilepsy in Sweden. ISPOR (International Society for Pharmacoeconomics and Outcomes Research) 2006 In: Value in Health. - 1098-3015. ; 9:3, s. 84-84 Conference paper (other academic/artistic)
4.	Akerborg, O, et al. (author) DRONEDARONE IN ATRIAL FIBRILLATION: MODELING HEALTH OUTCOMES 2009 In: VALUE IN HEALTH. - 1098-3015. ; 12:7, s. A335-A335 Conference paper (other academic/artistic)
5.	Andlin-Sobocki, P, et al. (author) Cost of affective disorders in Europe 2005 In: VALUE IN HEALTH. - 1098-3015. ; 8:6, s. A210-A210 Conference paper (other academic/artistic)
6.	Andlin-Sobocki, P, et al. (author) Estimating the cost of illness in EUROPE - A model with multiple sclerosis as an example 2004 In: VALUE IN HEALTH. - 1098-3015. ; 7:6, s. 796-797 Conference paper (other academic/artistic)
7.	Berg, J, et al. (author) Cost-effectiveness of clopidogrel in myocardial infarction with ST-segment elevation: European model results based on clarity and commit 2006 In: VALUE IN HEALTH. - 1098-3015. ; 9:6, s. A346-A347 Conference paper (other academic/artistic)
8.	Berg, J, et al. (author) Economic evaluation of a new airway inflammation monitor in the diagnosis and management of asthma in Germany 2006 In: VALUE IN HEALTH. - 1098-3015. ; 9:6, s. A333-A333 Conference paper (other academic/artistic)
9.	Berg, J, et al. (author) Economic evaluation of a new airway inflammation monitor in the diagnosis and management of asthma in the US 2007 In: VALUE IN HEALTH. - 1098-3015. ; 10:3, s. A110-A110 Conference paper (other academic/artistic)
10.	Berg, J, et al. (author) FACTORS DETERMINING UTILITY MEASURED WITH THE EQ-5D IN PATIENTS WITH ATRIAL FIBRILLATION 2008 In: VALUE IN HEALTH. - 1098-3015. ; 11:6, s. A410-A410 Conference paper (other academic/artistic)
11.	Berg, J, et al. (author) The cost of multiple sclerosis (MS) in Europe 2005 In: VALUE IN HEALTH. - 1098-3015. ; 8:6, s. A134-A134 Conference paper (other academic/artistic)
12.	Bingefors, C, et al. (author) Health state utilities in patients with dermatological problems - A population study 2002 In: VALUE IN HEALTH. - 1098-3015. ; 5:6, s. 560-561 Conference paper (other academic/artistic)
13.	Cammarota, S, et al. (author) HEALTH-CARE COSTS ASSOCIATED WITH BREAST CANCER MANAGEMENT 2010 In: VALUE IN HEALTH. - 1098-3015. ; 13:7, s. A278-A278 Conference paper (other academic/artistic)
14.	Cammarota, S, et al. (author) IMAGING TESTS IN STAGING AND SURVEILLANCE OF EARLY BREAST CANCER (EBC) IN ITALY-CHANGES IN ROUTINE CLINICAL PRACTICE AND COSTS IMPLICATIONS 2010 In: VALUE IN HEALTH. - 1098-3015. ; 13:7, s. A279-A280 Conference paper (other academic/artistic)
15.	Citarella, A, et al. (author) COST IMPACT OF ORAL CAPECITABINE COMPARED TO 5-FLUOROURACIL FOR TREATMENT OF PATIENTS WITH METASTATIC COLORECTAL CANCER 2010 In: VALUE IN HEALTH. - 1098-3015. ; 13:7, s. A262-A262 Conference paper (other academic/artistic)
16.	Citarella, A, et al. (author) PHARMACOECONOMIC CONSEQUENCES OF LOSARTAN THERAPY IN PATIENTS UNDERGOING DIABETIC END-STAGE RENAL DISEASE IN EU AND USA 2010 In: VALUE IN HEALTH. - 1098-3015. ; 13:7, s. A294-A294 Conference paper (other academic/artistic)
17.	Clapham, E, et al. (author) ECONOMIC EVALUATION OF AGOMELATINE FOR MAJOR DEPRESSIVE DISORDER IN SWEDEN 2009 In: VALUE IN HEALTH. - 1098-3015. ; 12:3, s. A176-A176 Conference paper (other academic/artistic)
18.	Edwards, SJ, et al. (author) Proton pump inhibitors for the treatment of reflux oesophagitis: Endoscopic healing rates from a systematic review of randomised controlled trials 2006 In: VALUE IN HEALTH. - 1098-3015. ; 9:6, s. A241-A242 Conference paper (other academic/artistic)
19.	Ekman, M, et al. (author) THE SOCIETAL COST OF SCHIZOPHRENIA IN SWEDEN 2010 In: VALUE IN HEALTH. - 1098-3015. ; 13:3, s. A111-A112 Conference paper (other academic/artistic)
20.	Farkkila, N, et al. (author) Economic evaluation of switching to exemestane at 2-3 years versus continuing tamoxifen as adjuvant therapy in early breast cancer: A finnish perspective 2007 In: VALUE IN HEALTH. - 1098-3015. ; 10:6, s. A331-A331 Conference paper (other academic/artistic)
21.	Hagstromer, M, et al. (author) PATIENT REPORTED OUTCOMES IN THE EARLY STAGES OF MULTIPLE SCLEROSIS: THE BEGIN STUDY 2009 In: VALUE IN HEALTH. - 1098-3015. ; 12:7, s. A373-A373 Conference paper (other academic/artistic)
22.	Jansson, SA, et al. (author) Costs of COPD in Sweden according to disease severity 2007 In: VALUE IN HEALTH. - 1098-3015. ; 10:6, s. A307-A307 Conference paper (other academic/artistic)
23.	Johansson, S, et al. (author) Risk of upper gastrointestinal adverse events and the effect of acid-suppressive theraphy in patients receiving acetylsalicylic acid for cardiovascular risk management 2009 In: Value in Health. - 1098-3015 .- 1524-4733. ; 12:3, s. A58- Journal article (peer-reviewed)
24.	Jonsson, L, et al. (author) A multi-domain micro-simulation economic modeling framework in Alzheimer's disease 2007 In: VALUE IN HEALTH. - 1098-3015. ; 10:3, s. A83-A83 Conference paper (other academic/artistic)
25.	Kasteng, F, et al. (author) Cost-effectiveness of human interferon-alpha as adjuvant treatment for patients with resected cutaneous malignant melanoma in stage IIB & III 2007 In: VALUE IN HEALTH. - 1098-3015. ; 10:6, s. A330-A330 Conference paper (other academic/artistic)

Skapa referenser, mejla, bekava och länka

Permalink

Träfflista för sökning "L773:1098 3015 "

Refine your search

Year